The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mcclellan William D. Jr. since 2017.
This trader's CIK number is 1689402.
At the time of last reporting, Mcclellan William D. Jr. was the Director of Reata Pharmaceuticals Inc. (stock ticker symbol RETA).
Also see all insider trading activities at Reata Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | APEN | 2,000 | $12,567 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RETA | 0 | $0 | 5,000 | $822,440 | 0 | $0 |
| 2020 | RETA | 0 | $0 | 8,000 | $1,294,004 | 0 | $0 |
1. Apollo Endosurgery, Inc. (APEN)
2. Reata Pharmaceuticals Inc (RETA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-05-17 | APEN | Buy | 1,700 | 6.30 | 10,710 |
| 2017-05-16 | APEN | Buy | 300 | 6.19 | 1,857 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-28 | RETA | Sale | 5,000 | 164.49 | 822,440 |
| 2020-11-12 | RETA | Sale | 4,000 | 173.49 | 693,964 |
| 2020-11-09 | RETA | Sale | 4,000 | 150.01 | 600,040 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcclellan William D. Jr. (Director of Reata Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.